Indonesia adopts remdesivir as Malaysia shops for COVID vaccines

Southeast Asian neighbors reveal their latest steps to tackle pandemic

20201001 remdesivir

Indonesia is turning to the antiviral drug remdesivir as it struggles to cope with over 4,000 new COVID-19 patients per day.  © Reuters

ERWIDA MAULIA and P PREM KUMAR, Nikkei staff writers

JAKARTA/KUALA LUMPUR -- Indonesia and Malaysia are scurrying to beef up their capabilities to treat and stop COVID-19, as their infection trajectories raise alarm.

Sponsored Content

About Sponsored ContentThis content was commissioned by Nikkei's Global Business Bureau.